Becton Dickinson (NYSE:BDX) has recently announced the appointment of Bilal Muhsin as Executive Vice President, tasked with leading the company's future Connected Care segment. Despite this ...

This was the stock's third consecutive day of losses.

We came across a bullish thesis on Becton, Dickinson and Company on Disruptive Analytics’ Substack by Magnus Ofstad. In this ...

Medtronic is bringing on a medical device industry veteran for its new top lawyer as it prepares for a major organizational ...

It is hard to get excited after looking at Becton Dickinson's (NYSE:BDX) recent performance, when its stock has declined 24% over the past three months. We, however decided to study the company's ...

Fong replaced Brad Lerman as Medtronic’s GC, who retired in 2022 before being lured out of retirement to become CLO at ...

The global enteral feeding devices market, valued at US$2,807.9 million in 2024, stood at US$2,965.1 million in 2025 and is ...

Market OutlineThe Global Cell Isolation Market is valued at USD 15.6 Billion in 2024 and is projected to attain a value of USD 60.56 Billion by 2035 at a CAGR of 13.15% during the forecast period 2025 ...

A high-level overview of Becton, Dickinson and Company (BDX) stock. View (BDX) real-time stock price, chart, news, analysis, analyst reviews and more.

Shares of Becton Dickinson and Company BDX are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting ...